stockrowEvolus, Inc. (EOLS) vs Tilray Brands, Inc. (TLRY)
- Evolus, Inc. EOLS 6.84 +0.59%
- Tilray Brands, Inc. TLRY 2.79 −0.71%
Evolus, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. and Tilray Brands, Inc. are of similar size ($448.8M and $415.3M). Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 13.9%. Evolus, Inc. has the higher net margin (−9.56% vs −17.1%) and the lower return on invested capital (−12.6% vs −3.21%). Across the 17 metrics below, Evolus, Inc. leads on 10 and Tilray Brands, Inc. on 7.
Valuation
Profitability
| Metric | EOLS | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.38% | 29.12% | 53.51% |
| Operating margin | (4.79%) | (9.26%) | 0.00% |
| Net margin | (9.56%) | (17.05%) | (2.45%) |
| Free cash flow margin | (2.71%) | (19.10%) | 0.00% |
| Return on equity | 93.47% | (10.50%) | (0.80%) |
| Return on assets | (12.38%) | (7.45%) | (1.67%) |
| Return on invested capital | (12.60%) | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack